Daphna M Finn1, Brian M Ilfeld2,3, Jonathan T Unkart4, Sarah J Madison5, Preetham J Suresh5, Nav Parkash S Sandhu5, Nicholas J Kormylo5, Nisha Malhotra5,6, Vanessa J Loland5,7, Mark S Wallace5, Cindy H Wen8, Anya C Morgan5, Anne M Wallace4. 1. Department of Psychiatry, University of California San Diego, 200 West Arbor Drive, San Diego, CA, 92103, USA. 2. Department of Anesthesiology, University of California San Diego, 200 West Arbor Drive, San Diego, CA, 92103, USA. bilfeld@ucsd.edu. 3. Department of Anesthesiology, Outcomes Research Consortium, Cleveland, OH, USA. bilfeld@ucsd.edu. 4. Department of Surgery, University of California San Diego, 200 West Arbor Drive, San Diego, CA, 92103, USA. 5. Department of Anesthesiology, University of California San Diego, 200 West Arbor Drive, San Diego, CA, 92103, USA. 6. Department of Anesthesiology, Lawrence and Memorial Hospital, New London, CT, USA. 7. Department of Anesthesiology, University of Washington, Seattle, WA, USA. 8. Department of Ophthalmology, University of California San Diego, 200 West Arbor Drive, San Diego, CA, 92103, USA.
Abstract
PURPOSE: Retrospective studies have associated perioperative regional anesthesia/analgesia during mastectomy for breast cancer with a decreased incidence of cancer recurrence. However, to date, no prospective data from a randomized controlled trial have been reported. In a previous study we found that extending a single-injection paravertebral block with a multiple-day perineural local anesthetic infusion improves analgesia. This follow-up study investigates the rates of cancer recurrence for the single-injection and multiple-day infusion treatments. METHODS:Patients undergoing unilateral (n = 24) or bilateral mastectomy (n = 36) were included in the study. All patients had been diagnosed with breast cancer or tumor in situ, except for six patients who were receivingprophylactic bilateral mastectomy and were excluded from analyses. Patients received unilateral or bilateral single-injection thoracic paravertebral block(s) corresponding to their surgical site(s) with ropivacaine and perineural catheter(s). Subsequently, patients were randomized to receive either ropivacaine 0.4% (n = 30) or normal saline (n = 30) via their catheter(s) until catheter removal on postoperative day 3. Cancer recurrence from the date of surgery until at least 2 years post surgery was investigated via chart review. RESULTS: Five of the 54 (9.2%) patients experienced a cancer recurrence following mastectomy-3 of 26 (11.5%) of the patients with perineural ropivacaine and 2 of 28 (7.1%) of the patients with perineural saline. CONCLUSIONS: This pilot study found no evidence that extending a single-injection paravertebral block with a multi-day perineural local anesthetic infusion decreases the risk of post-mastectomy cancer recurrence. However, due to the small sample size of this investigation, further research is needed to draw definitive conclusions.
RCT Entities:
PURPOSE: Retrospective studies have associated perioperative regional anesthesia/analgesia during mastectomy for breast cancer with a decreased incidence of cancer recurrence. However, to date, no prospective data from a randomized controlled trial have been reported. In a previous study we found that extending a single-injection paravertebral block with a multiple-day perineural local anesthetic infusion improves analgesia. This follow-up study investigates the rates of cancer recurrence for the single-injection and multiple-day infusion treatments. METHODS:Patients undergoing unilateral (n = 24) or bilateral mastectomy (n = 36) were included in the study. All patients had been diagnosed with breast cancer or tumor in situ, except for six patients who were receiving prophylactic bilateral mastectomy and were excluded from analyses. Patients received unilateral or bilateral single-injection thoracic paravertebral block(s) corresponding to their surgical site(s) with ropivacaine and perineural catheter(s). Subsequently, patients were randomized to receive either ropivacaine 0.4% (n = 30) or normal saline (n = 30) via their catheter(s) until catheter removal on postoperative day 3. Cancer recurrence from the date of surgery until at least 2 years post surgery was investigated via chart review. RESULTS: Five of the 54 (9.2%) patients experienced a cancer recurrence following mastectomy-3 of 26 (11.5%) of the patients with perineural ropivacaine and 2 of 28 (7.1%) of the patients with perineural saline. CONCLUSIONS: This pilot study found no evidence that extending a single-injection paravertebral block with a multi-day perineural local anesthetic infusion decreases the risk of post-mastectomy cancer recurrence. However, due to the small sample size of this investigation, further research is needed to draw definitive conclusions.
Entities:
Keywords:
Cancer recurrence; Continuous paravertebral block; Mastectomy
Authors: Gildasio S de Oliveira; Shireen Ahmad; Julian C Schink; Diljeet K Singh; Paul C Fitzgerald; Robert J McCarthy Journal: Reg Anesth Pain Med Date: 2011 May-Jun Impact factor: 6.288
Authors: Aristomenis K Exadaktylos; Donal J Buggy; Denis C Moriarty; Edward Mascha; Daniel I Sessler Journal: Anesthesiology Date: 2006-10 Impact factor: 7.892
Authors: Brian M Ilfeld; Sarah J Madison; Preetham J Suresh; NavParkash S Sandhu; Nicholas J Kormylo; Nisha Malhotra; Vanessa J Loland; Mark S Wallace; Edward J Mascha; Zekun Xu; Cindy H Wen; Anya C Morgan; Anne M Wallace Journal: Ann Surg Oncol Date: 2014-11-21 Impact factor: 5.344
Authors: Rose Christopherson; Kenneth E James; Mara Tableman; Prudence Marshall; Frank E Johnson Journal: Anesth Analg Date: 2008-07 Impact factor: 5.108
Authors: Kalpna Gupta; Smita Kshirsagar; Liming Chang; Robert Schwartz; Ping-Y Law; Doug Yee; Robert P Hebbel Journal: Cancer Res Date: 2002-08-01 Impact factor: 12.701
Authors: Giacomo Montagna; Hersh V Gupta; Margaret Hannum; Kay See Tan; Jasme Lee; Joseph R Scarpa; George Plitas; Takeshi Irie; Patrick J McCormick; Gregory W Fischer; Monica Morrow; Joshua S Mincer Journal: Br J Anaesth Date: 2020-11-19 Impact factor: 9.166